SHARE

Tilray buys Lyphe Group to build integrated UK medical cannabis platform

Tilray Brands has acquired UK-based Lyphe Group to expand Tilray Medical’s presence. Lyphe has dispensed about 150,000 units and treated over 16,000 patients. Tilray says the deal creates its first fully integrated, patient-centric platform.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.